Dr. Karen Wright, MD

Claim this profile

Dana-Farber Cancer Institute

Studies Benign Glioma
Studies Brain Tumor
4 reported clinical trials
6 drugs studied

Area of expertise

1Benign Glioma
Karen Wright, MD has run 4 trials for Benign Glioma. Some of their research focus areas include:
RAS positive
RAF positive
MEK positive
2Brain Tumor
Karen Wright, MD has run 4 trials for Brain Tumor. Some of their research focus areas include:
RAS positive
RAF positive
MEK positive

Affiliated Hospitals

Image of trial facility.
Dana Farber Cancer Institute
Image of trial facility.
Dana-Farber Cancer Institite

Clinical Trials Karen Wright, MD is currently running

Image of trial facility.

PEP-CMV Vaccine

for Pediatric Brain Tumor

This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP) of 26 amino acid residues from human pp65. The SLPs encode multiple potential class I, class II, and antibody epitopes across several haplotypes. Component A will be administered as a stable water:oil emulsion in Montanide ISA 51. Funding Source - FDA OOPD
Recruiting1 award Phase 2

More about Karen Wright, MD

Clinical Trial Related7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Karen Wright, MD has experience with
  • Tovorafenib/DAY101
  • PTC596
  • Radiotherapy
  • PEP-CMV Vaccine
  • Dabrafenib
  • Trametinib
Breakdown of trials Karen Wright, MD has run
Benign Glioma
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Medulloblastoma
Relapse

Other Doctors you might be interested in

Sapna Syngal, MDDana Farber Cancer Center, Harvard University
David Lieberman, MD, PhDBoston Children's Hospital
Gregory Cote, MDDana-Farber - Harvard Cancer Center LAO

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Wright, MD specialize in?
Karen Wright, MD focuses on Benign Glioma and Brain Tumor. In particular, much of their work with Benign Glioma has involved RAS positive patients, or patients who are RAF positive.
Is Karen Wright, MD currently recruiting for clinical trials?
Yes, Karen Wright, MD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Karen Wright, MD has studied deeply?
Yes, Karen Wright, MD has studied treatments such as Tovorafenib/DAY101, PTC596, Radiotherapy.
What is the best way to schedule an appointment with Karen Wright, MD?
Apply for one of the trials that Karen Wright, MD is conducting.
What is the office address of Karen Wright, MD?
The office of Karen Wright, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top